Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Dec 24:8:808719.
doi: 10.3389/fmed.2021.808719. eCollection 2021.

Ex-vivo Kidney Machine Perfusion: Therapeutic Potential

Affiliations
Review

Ex-vivo Kidney Machine Perfusion: Therapeutic Potential

Ruta Zulpaite et al. Front Med (Lausanne). .

Abstract

Kidney transplantation remains the gold standard treatment for patients suffering from end-stage kidney disease. To meet the constantly growing organ demands grafts donated after circulatory death (DCD) or retrieved from extended criteria donors (ECD) are increasingly utilized. Not surprisingly, usage of those organs is challenging due to their susceptibility to ischemia-reperfusion injury, high immunogenicity, and demanding immune regulation after implantation. Lately, a lot of effort has been put into improvement of kidney preservation strategies. After demonstrating a definite advantage over static cold storage in reduction of delayed graft function rates in randomized-controlled clinical trials, hypothermic machine perfusion has already found its place in clinical practice of kidney transplantation. Nevertheless, an active investigation of perfusion variables, such as temperature (normothermic or subnormothermic), oxygen supply and perfusate composition, is already bringing evidence that ex-vivo machine perfusion has a potential not only to maintain kidney viability, but also serve as a platform for organ conditioning, targeted treatment and even improve its quality. Many different therapies, including pharmacological agents, gene therapy, mesenchymal stromal cells, or nanoparticles (NPs), have been successfully delivered directly to the kidney during ex-vivo machine perfusion in experimental models, making a big step toward achievement of two main goals in transplant surgery: minimization of graft ischemia-reperfusion injury and reduction of immunogenicity (or even reaching tolerance). In this comprehensive review current state of evidence regarding ex-vivo kidney machine perfusion and its capacity in kidney graft treatment is presented. Moreover, challenges in application of these novel techniques in clinical practice are discussed.

Keywords: ex-vivo machine perfusion; ex-vivo therapy; graft preservation; graft rejection; ischemia-reperfusion injury; kidney preconditioning; kidney transplantation; organ regeneration.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Similar articles

Cited by

References

    1. Eurotransplant–Statistics. (2020). Available online at: https://statistics.eurotransplant.org/index.php?search_type=waiting+list... (accessed November 22, 2021).
    1. Summers DM, Johnson RJ, Hudson A, Collett D, Watson CJ, Bradley JA. Effect of donor age and cold storage time on outcome in recipients of kidneys donated after circulatory death in the UK: a cohort study. Lancet. (2013) 381:727–34. 10.1016/S0140-6736(12)61685-7 - DOI - PubMed
    1. Summers DM, Johnson RJ, Allen J, Fuggle SV, Collett D, Watson CJ, et al. . Analysis of factors that affect outcome after transplantation of kidneys donated after cardiac death in the UK: a cohort study. Lancet. (2010) 376:1303–11. 10.1016/S0140-6736(10)60827-6 - DOI - PubMed
    1. Rao PS, Ojo A. The alphabet soup of kidney transplantation: SCD, DCD, ECD–fundamentals for the practicing nephrologist. Clin J Am Soc Nephrol. (2009) 4:1827–31. 10.2215/CJN.02270409 - DOI - PubMed
    1. Jochmans I, Akhtar MZ, Nasralla D, Kocabayoglu P, Boffa C, Kaisar M, et al. . Past, present, and future of dynamic kidney and liver preservation and resuscitation. Am J Transplant. (2016) 16:2545–55. 10.1111/ajt.13778 - DOI - PubMed

LinkOut - more resources